RHOA and triple-A syndrome: AAA formation was significantly reduced by intravenous treatment with DMX-5804 in addition to AngII and BAPN in RhoA cKO mice, with no change in hemodynamics (Table 2, Fig. 6a and Supplementary Fig. 7a).